Newsroom
January 24, 2022
Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]
January 19, 2022
Region of protein can be therapy target in pediatric myelodysplastic syndrome. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 19, 2022) — Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism […]
January 12, 2022
Dr. Virginia Kaklamani, Medicine/Hematology-Oncology and Mays Cancer Center, is the moderator of the discussion presented below. This is the third installment of a series. The experts comment on clinical trials and genomic profiling in patients with metastatic breast cancer. Read More
January 6, 2022
Dr. Virginia Kaklamani, Medicine/Hematology-Oncology and Mays Cancer Center, is quoted in this article. Read story
January 6, 2022
The University of Texas System has awarded Peng Zhao, PhD, a Rising STARs Award. Dr. Zhao is an assistant professor of biochemistry and structural biology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio).
January 5, 2022
Dr. Virginia Kaklamani, Medicine/Hematology-Oncology and Mays Cancer Center, is the moderator of the discussion presented in this article. The experts comment on two clinical trials of selective estrogen receptor degraders (SERDs) for treatment of metastatic breast cancer. Results of both trials were presented at the San Antonio Breast Cancer Symposium. Read story